1971 - 1980 of 6230 Results
Title
Year
- Early Autonomic Symptoms Predict Functional Decline in Parkinson’s Disease Independent of Dopaminergic Therapy2022OPENTitle: Early Autonomic Symptoms Predict Functional Decline in Parkinson’s Disease Independent of Dopaminergic TherapyJournal Name: Neurodegenerative DiseasesPublisher: S. Karger AGVol: 22Issue #: 1Start Page: 15End Page: 23Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000525664Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9671814Citation Count: 3
- Deep Learning–based Approach for Brainstem and Ventricular MR Planimetry: Application in Patients with Progressive Supranuclear Palsy2024OPENTitle: Deep Learning–based Approach for Brainstem and Ventricular MR Planimetry: Application in Patients with Progressive Supranuclear PalsyJournal Name: Radiology: Artificial IntelligencePublisher: Radiological Society of North America (RSNA)Vol: 6Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1148/ryai.230151Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11140505Citation Count: 4
- Longitudinal decline in striatal dopamine transporter binding in Parkinson’s disease: associations with apathy and anhedonia2023OPENTitle: Longitudinal decline in striatal dopamine transporter binding in Parkinson’s disease: associations with apathy and anhedoniaJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 94Issue #: 10Start Page: 863End Page: 870Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1136/jnnp-2022-330790Best OA location URL: https://jnnp.bmj.com/content/jnnp/early/2023/05/25/jnnp-2022-330790.full.pdfCitation Count: 19
- Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts2022OPENTitle: Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohortsJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 93Issue #: 9Start Page: 952End Page: 959Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1136/jnnp-2021-327376Best OA location URL: https://jnnp.bmj.com/content/jnnp/93/9/952.full.pdfCitation Count: 11
-
OPENTitle: Parkinson’s disease psychosis associated with accelerated multidomain cognitive declineJournal Name: BMJ Mental HealthPublisher: BMJVol: 27Issue #: 1Start Page: e301062End Page: e301062Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjment-2024-301062Best OA location URL: https://doi.org/10.1136/bmjment-2024-301062Citation Count: 8
- Classification of GBA1 variants and their impact on Parkinson’s disease: an in silico score analysis2025OPENTitle: Classification of GBA1 variants and their impact on Parkinson’s disease: an in silico score analysisJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01060-6Best OA location URL: https://www.nature.com/articles/s41531-025-01060-6.pdfCitation Count: 0
- Dopamine and cortical neurons with different Parkinsonian mutations show variation in lysosomal and mitochondrial dysfunction2025OPENTitle: Dopamine and cortical neurons with different Parkinsonian mutations show variation in lysosomal and mitochondrial dysfunctionJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01048-2Best OA location URL: https://www.nature.com/articles/s41531-025-01048-2.pdfCitation Count: 0
- Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trials2025OPENTitle: Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trialsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01041-9Best OA location URL: https://www.nature.com/articles/s41531-025-01041-9.pdfCitation Count: 0
- Wrist accelerometry and machine learning sensitively capture disease progression in prodromal Parkinson’s disease2025OPENTitle: Wrist accelerometry and machine learning sensitively capture disease progression in prodromal Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-025-01034-8Best OA location URL: https://www.nature.com/articles/s41531-025-01034-8.pdfCitation Count: 0
- Peripheral inflammation’s variable impact on cognitive and symptomatic outcomes in Parkinson’s disease: a longitudinal and cross-sectional analysis2025OPENTitle: Peripheral inflammation’s variable impact on cognitive and symptomatic outcomes in Parkinson’s disease: a longitudinal and cross-sectional analysisJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-025-01019-7Best OA location URL: https://www.nature.com/articles/s41531-025-01019-7.pdfCitation Count: 0